MDN-001 Injection for the Treatment of Unresectable Primary Hepatocellular Carcinoma.

NCT07391839 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Hepatoma
Unresectable Hepatocellular Carcinoma (HCC)

Interventions

DRUG: MDN-001 Injection(Yttrium-90 Microsphere Injection)

Sponsor

Suzhou Mednovo Yi Medical Technology Co., Ltd.